|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| C07K 16/28 | (2006.01) | ||
| A61K 31/4184 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 2464382 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10747168.2 |
| Date of filing the European patent application | 2010-08-12 | |
| (97) | Date of publication of the European application | 2012-06-20 |
| (45) | Date of publication and mention of the grant of the patent | 2017-05-03 |
| (46) | Date of publication of the claims translation | 2017-07-25 |
| (86) | Number | PCT/EP2010/004939 |
| Date | 2010-08-12 |
| (87) | Number | WO 2011/018224 |
| Date | 2011-02-17 |
| (30) | Number | Date | Country code |
| 09010489 | 2009-08-14 | EP |
| (72) |
HERTING, Frank, DE
KLEIN, Christian, CH
|
| (73) |
Roche Glycart AG,
Wagistrasse 18, 8952 Schlieren-Zuerich,
CH
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Gydymas afukozintu anti-CD20 antikūnu kartu su bendamustinu |
| COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH BENDAMUSTINE |
| Payment date | Validity (years) | Amount | |
| 2025-07-23 | 16 | 347.00 EUR |
| 2026-08-12 |